Literature DB >> 18759868

Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP).

Supamai Soonthornpun1, Worawong Setasuban, Atchara Thamprasit.   

Abstract

BACKGROUND: Hyperinsulinaemia has been suggested as an important factor for developing hypokalaemic paralysis in patients with thyrotoxic periodic paralysis (TPP). Since hyperinsulinaemia is a common feature of insulin resistance, there may be a causal relationship between insulin resistance and TPP.
OBJECTIVE: To compare insulin sensitivity between subjects with a history of TPP and others with a history of thyrotoxicosis without periodic paralysis.
METHODS: Insulin sensitivity measured by euglycaemic hyperinsulinaemic clamp and 75-g oral glucose tolerance test (OGTT) were performed nonselectively in 10 subjects with a history of TPP (TPP group) and 10 age- and sex-matched subjects with a history of simple thyrotoxicosis (control group). All participants had euthyroidism and fasting plasma glucose of < 5.55 mmol/l at the time of the study.
RESULTS: Body mass index and waist circumference of the TPP group were higher than that of the control group. One of 10 (10%) subjects in the TPP group and 6 of 10 (60%) in the control group had BMI of < 23 kg/m2. Areas under the curve (AUC) of plasma glucose after OGTT were comparable, while the AUC of serum insulin of the TPP group was higher than in the control group. The TPP group had lower insulin sensitivity than the control group.
CONCLUSION: The subjects with a history of TPP were more obese and had lower insulin sensitivity than those with a history of simple thyrotoxicosis. Insulin resistance with compensatory hyperinsulinaemia may be a key feature of the pathogenesis of TPP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18759868     DOI: 10.1111/j.1365-2265.2008.03395.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  13 in total

1.  Thyrotoxic hypokalaemic periodic paralysis: a rare presentation of Graves' disease in a Hispanic patient.

Authors:  Abhishek Matta; Jahnavi Koppala; William Gossman
Journal:  BMJ Case Rep       Date:  2014-04-09

Review 2.  Novel etiopathophysiological aspects of thyrotoxic periodic paralysis.

Authors:  Rui M B Maciel; Susan C Lindsey; Magnus R Dias da Silva
Journal:  Nat Rev Endocrinol       Date:  2011-05-10       Impact factor: 43.330

3.  Pop-provoked paralysis: silent Graves' disease presenting as thyrotoxic periodic paralysis.

Authors:  Benjamin Sehmer; Terra Arnason
Journal:  BMJ Case Rep       Date:  2012-11-30

Review 4.  Thyrotoxic periodic paralysis: clinical and molecular aspects.

Authors:  Henrik Falhammar; Marja Thorén; Jan Calissendorff
Journal:  Endocrine       Date:  2012-08-24       Impact factor: 3.633

5.  Thyrotoxic Periodic Paralysis: Case Reports and an Up-to-Date Review of the Literature.

Authors:  Abbi Lulsegged; Christina Wlodek; Michela Rossi
Journal:  Case Rep Endocrinol       Date:  2011-09-22

6.  Thyrotoxic periodic paralysis: a case study and review of the literature.

Authors:  Marcelle Meseeha; Behnaz Parsamehr; Kerri Kissell; Maximos Attia
Journal:  J Community Hosp Intern Med Perspect       Date:  2017-06-06

7.  An atypical presentation of high potassium renal secretion rate in a patient with thyrotoxic periodic paralysis: a case report.

Authors:  Mei-Lan Tu; Yu-Wei Fang; Jyh-Gang Leu; Ming-Hsien Tsai
Journal:  BMC Nephrol       Date:  2018-07-04       Impact factor: 2.388

8.  Levothyroxine and prednisone causing generalized weakness in a middle-aged man.

Authors:  Andrew Word; Kevin Davidson; Essam Elsayed
Journal:  Case Rep Endocrinol       Date:  2012-10-18

Review 9.  Thyrotoxic periodic paralysis: clinical challenges.

Authors:  Abhishek Vijayakumar; Giridhar Ashwath; Durganna Thimmappa
Journal:  J Thyroid Res       Date:  2014-02-20

10.  Thyrotoxic Periodic Paralysis: An Incidental Diagnosis!

Authors:  Jennifer T Batch; Muhammad U Jahngir; Ismael Rodriguez
Journal:  Cureus       Date:  2020-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.